Search Results - "ZAMAMI, Yoshito"

Refine Results
  1. 1

    Differences in risk factors for anticoagulant‐related nephropathy between warfarin and direct oral anticoagulants: Analysis of the Japanese adverse drug event report database by Mitsuboshi, Satoru, Niimura, Takahiro, Zamami, Yoshito, Ishizawa, Keisuke

    Published in British journal of clinical pharmacology (01-07-2021)
    “…Limited information is available on anticoagulant‐related nephropathy (ARN). We therefore reviewed the Japanese Adverse Drug Event Report database to…”
    Get full text
    Journal Article
  2. 2

    Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study by Okada, Naoto, Matsuoka, Rie, Sakurada, Takumi, Goda, Mitsuhiro, Chuma, Masayuki, Yagi, Kenta, Zamami, Yoshito, Nishioka, Yasuhiko, Ishizawa, Keisuke

    Published in Scientific reports (13-08-2020)
    “…Immune checkpoint inhibitors (ICIs) elicit antitumour effects by activating the host immunity and cause immune-related adverse events (irAEs). ICI-related…”
    Get full text
    Journal Article
  3. 3

    Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database by Mikami, Takahisa, Liaw, Bobby, Asada, Mizuho, Niimura, Takahiro, Zamami, Yoshito, Green-LaRoche, Deborah, Pai, Lori, Levy, Michael, Jeyapalan, Suriya

    Published in Journal of neuro-oncology (01-03-2021)
    “…Purpose To investigate the characteristics and risk factors for neurologic adverse events (AEs) induced by immune checkpoint inhibitors (ICIs). Methods An…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Polypharmacy in Older Adults with Alzheimer’s Disease by Esumi, Satoru, Ushio, Soichiro, Zamami, Yoshito

    Published in Medicina (Kaunas, Lithuania) (13-10-2022)
    “…The number of patients with Alzheimer’s disease is increasing annually. Most of these patients are older adults with comorbid physical illnesses, which means…”
    Get full text
    Journal Article
  6. 6

    Effect of Lipopolysaccharide on the Duration of Zolpidem-Induced Loss of Righting Reflex in Mice by Wada, Yudai, Ushio, Soichiro, Kitamura, Yoshihisa, Zamami, Yoshito, Sendo, Toshiaki

    Published in Acta medica Okayama (01-06-2024)
    “…Zolpidem, a non-benzodiazepine hypnotic, is primarily used to treat insomnia. In a previous study, pior treatment with non-benzodiazepine receptor agonists was…”
    Get full text
    Journal Article
  7. 7

    Trends in Polypharmacy in Japan: A Nationwide Retrospective Study by Onoue, Hiroshi, Koyama, Toshihiro, Zamami, Yoshito, Hagiya, Hideharu, Tatebe, Yasuhisa, Mikami, Naoko, Shinomiya, Kazuaki, Kitamura, Yoshihisa, Hinotsu, Shiro, Sendo, Toshiaki, Ouchi, Yasuyoshi, Kano, Mitsunobu R.

    “…Objectives To describe and examine trends in polypharmacy according to age in Japan from 2010 to 2016. Design Retrospective observational study. Setting…”
    Get full text
    Journal Article
  8. 8

    Ameliorating effect of chotosan and its active component, Uncaria hook, on lipopolysaccharide-induced anxiety-like behavior in mice by Okawa, Yasumasa, Ushio, Soichiro, Izushi, Yasuhisa, Kitamura, Yoshihisa, Zamami, Yoshito, Sendo, Toshiaki

    Published in Frontiers in pharmacology (04-09-2024)
    “…In this study, we aimed to examine the effects of chotosan, a traditional Japanese botanical drug, and its active component, hook, on anxiety-like behaviors…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects by Nawa, Hideki, Niimura, Takahiro, Hamano, Hirofumi, Yagi, Kenta, Goda, Mitsuhiro, Zamami, Yoshito, Ishizawa, Keisuke

    Published in Frontiers in pharmacology (09-06-2021)
    “…From 2002 to 2018, the number of patients with prostate cancer significantly increased from 679,023 to 1276,106 worldwide. Total prostatectomy (including…”
    Get full text
    Journal Article
  13. 13

    Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases by Mitsuboshi, Satoru, Hamano, Hirofumi, Kuniki, Yurika, Niimura, Takahiro, Chuma, Masayuki, Ushio, Soichiro, Lin, Tsung-Jen, Matsumoto, Jun, Takeda, Tatsuaki, Kajizono, Makoto, Zamami, Yoshito, Ishizawa, Keisuke

    Published in The Annals of pharmacotherapy (01-11-2023)
    “…Background: It is unclear whether use of a proton pump inhibitors (PPIs) increases the risk of rhabdomyolysis. Objective: To clarify whether use of PPIs…”
    Get full text
    Journal Article
  14. 14

    Effect of Nerve Growth Factor on Innervation of Perivascular Nerves in Neovasculatures of Mouse Cornea by Matsuyama, Akiko, Takatori, Shingo, Sone, Yoko, Ochi, Eiko, Goda, Mitsuhiro, Zamami, Yoshito, Hashikawa-Hobara, Narumi, Kitamura, Yoshihisa, Kawasaki, Hiromu

    “…Angiogenesis, which is the generation of new vascular networks from existing blood vessels, occurs under normal and pathophysiological conditions. Perivascular…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis by Imakura, Takeshi, Sato, Seidai, Koyama, Kazuya, Ogawa, Hirohisa, Niimura, Takahiro, Murakami, Kojin, Yamashita, Yuya, Haji, Keiko, Naito, Nobuhito, Kagawa, Kozo, Kawano, Hiroshi, Zamami, Yoshito, Ishizawa, Keisuke, Nishioka, Yasuhiko

    Published in Respiratory research (02-06-2023)
    “…Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease with few effective therapeutic options. Recently, drug repositioning, which involves…”
    Get full text
    Journal Article
  19. 19

    Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database by Mitsuboshi, Satoru, Niimura, Takahiro, Yoshino, Masaki, Sakamoto, Yoshika, Zamami, Yoshito, Ishizawa, Keisuke

    Published in International journal of clinical pharmacy (01-02-2022)
    “…Background The association between fluoropyrimidines except for capecitabine and the risk of hypertriglyceridemia is unclear. Objective To investigate…”
    Get full text
    Journal Article
  20. 20